Urethral cancer is a rare but serious malignancy affecting the tube that carries urine out of the body. India offers cutting-edge treatment with significantly lower costs, starting from $4,000 to $8,000 USD, while similar treatments in the USA exceed $35,000, and $15,000–$20,000 in Thailand. India’s oncologists, hospitals, and patient care make it a preferred destination for global cancer patients.
Urethral cancer refers to the abnormal and uncontrolled growth of malignant cells in the urethra. Although rare, it can be aggressive and often requires multidisciplinary treatment.
Squamous Cell Carcinoma – Most common; usually occurs in the bulbomembranous urethra.
Transitional Cell Carcinoma – Arises from the cells lining the urethra; more likely to spread to bladder.
Adenocarcinoma – Originates from glandular cells, less common but aggressive.
Risk Factors: Chronic urinary tract infections, urethral strictures, HPV infection, previous radiation therapy, and being over 60 years old.
India offers a holistic and internationally guided treatment protocol for urethral cancer, based on stage, tumor location, and histology.
Test |
Purpose |
Cost (USD) |
MRI Pelvis |
Tumor location and spread |
$150–$250 |
Cystoscopy |
Direct urethra visualization |
$80–$120 |
Biopsy |
Confirms cancer type |
$100–$150 |
PET-CT Scan |
Checks for metastasis |
$250–$400 |
Surgery:
Cost: $2,000 – $3,500
Chemotherapy:
Cost per cycle: $300–$500
Total cost (4–6 cycles): $1,200 – $2,500
Radiation Therapy:
Cost: $1,000 – $1,500
Immunotherapy (for recurrent/metastatic cases):
Drugs like Atezolizumab or Nivolumab
Cost: $3,000 – $5,000 per cycle
India is a global hub for cost-effective yet advanced oncology treatment, with outcomes comparable to top-tier Western hospitals. Here’s why:
Modern Infrastructure: Robotic surgery, IMRT/IGRT, PET-CT available in all major centers
Expertise: Oncologists trained at institutions like MD Anderson, Royal Marsden, etc.
Cost Advantage: Up to 80% cheaper than US/UK
Medical Tourism Services: Visa support, language translators, affordable stay options
No Waiting Times: Quick treatment access can be life-saving in cancer cases
Dr. Ankur Bahl, a senior medical oncologist at Fortis Memorial Research Institute (FMRI), Gurgaon, is one of India’s most respected cancer specialists, particularly in genitourinary oncology.
What sets him apart:
His team approach ensures coordination between surgeons, radiation oncologists, and palliative experts for holistic care.
Indian hospitals use internationally approved, state-of-the-art technologies that enable precision, minimally invasive approaches, and faster recovery.
Technology / Device |
Purpose |
Availability |
Flexible Cystoscopy |
Real-time urethral visualization |
Standard |
PET-CT & MRI |
Staging & metastasis detection |
Widely available |
Robotic Surgery (Da Vinci) |
Precise tumor resection with minimal damage |
Top hospitals |
IMRT/IGRT |
Advanced radiation therapy for accurate targeting |
Available |
Chemo Infusion Pumps |
Controlled and safe chemotherapy delivery |
All centers |
Histopathology with IHC |
Accurate diagnosis & tumor profiling |
Mandatory in protocols |
India’s technological ecosystem is comparable to that of the US or Europe, but comes at significantly lower costs.
Here is a realistic step-by-step cost estimate in both INR and USD:
Procedure / Test |
Estimated Cost (INR) |
Estimated Cost (USD) |
Consultation (1st + follow-ups) |
₹2,000–₹5,000 |
$25–$60 |
Blood Tests, LFT, KFT, CBC |
₹4,000–₹6,000 |
$50–$75 |
MRI Pelvis |
₹12,000–₹20,000 |
$150–$250 |
PET-CT Scan |
₹20,000–₹30,000 |
$250–$400 |
Cystoscopy + Biopsy |
₹8,000–₹12,000 |
$100–$150 |
Surgery (Urethrectomy/Partial Penectomy) |
₹1,80,000–₹3,00,000 |
$2,200–$3,500 |
Chemotherapy (4–6 cycles) |
₹1,00,000–₹2,00,000 |
$1,200–$2,500 |
Radiation Therapy (IMRT) |
₹80,000–₹1,20,000 |
$1,000–$1,500 |
Hospital Stay (5–7 days) |
₹30,000–₹60,000 |
$400–$750 |
Total Estimated Cost in India: ₹3.5 – ₹6.5 lakhs
Approximate USD Range: $4,000 – $8,000
Country |
Average Cost (USD) |
Cost Advantage in India |
USA |
$35,000 – $55,000 |
75–85% savings |
UK |
$30,000 – $45,000 |
70–80% savings |
Thailand |
$15,000 – $20,000 |
45–60% savings |
UAE |
$25,000 – $35,000 |
60–75% savings |
India |
$4,000 – $8,000 |
Affordable |
India provides an unmatched value proposition without compromising on quality or outcomes, making it ideal for uninsured or self-funded patients.
Indian hospitals provide end-to-end medical tourism support through international patient departments:
Service |
Description |
Medical Visa Assistance |
Invitation letters, embassy liaisons, fast-tracked processing |
Airport Transfers |
Pickup & drop by hospital-appointed drivers |
Accommodation Help |
Guest houses/hotels near hospitals from $20–$60/night |
Language Support |
Translators for Arabic, French, Swahili, Russian, Spanish |
Local SIM Cards & Forex |
Help with mobile connectivity and currency exchange |
Post-Treatment Follow-ups |
Teleconsultations, WhatsApp support, couriered reports |
Prognosis depends on tumor stage, location, and timely treatment:
Follow-up protocol:
India offers foreign patients with urethral cancer a rare combination of medical excellence, affordability, and holistic care. With highly experienced specialists like Dr. Ankur Bahl, global-class hospitals, and complete international patient support, India continues to be a global leader in cancer medical tourism. From early diagnosis to full recovery, India provides the assurance of effective treatment at globally competitive prices
Urethral cancer is a rare malignancy that affects the urethra—the tube that allows urine to exit the body. It accounts for less than 1% of all urological cancers. Though rare, it can be aggressive and requires prompt diagnosis and treatment, especially when the disease is locally advanced or metastatic.
These symptoms may mimic common urological issues, so early testing is critical for timely diagnosis.
Indian hospitals offer these tests with fast turnaround times and use advanced, globally approved equipment at a fraction of the cost in Western countries.
India provides these options through multidisciplinary teams, ensuring evidence-based care aligned with international protocols.
The total treatment cost ranges from $4,000 to $8,000 USD, depending on the stage, procedure, and medications required. This includes diagnostics, surgery, chemotherapy, hospital stay, and follow-up. In contrast, similar treatment may cost $35,000–$55,000 in the USA, making India an affordable yet high-quality destination.
Dr. Ankur Bahl is one of India's leading medical oncologists, based at Fortis Memorial Research Institute (FMRI), Gurgaon. He has over two decades of experience in treating complex genitourinary cancers like urethral carcinoma and is well-known among international patients for his personalized care, global exposure, and successful treatment outcomes.
These services ensure that foreign patients feel secure, supported, and comfortable throughout their medical journey in India.